$55m for Natural Cycles in Series C financing round
Lauxera Capital Partners led the round for the world's first birth control app
The world’s first birth control app, Natural Cycles, has announced today (30 May 2024) the closure of a Series C financing round led by Lauxera Capital partners.
The $55 million financing - with participation from Point72 Private Investments and a revolving debt facility from J.P. Morgan - will be used to invest in commercial acceleration, new product development, and healthcare reimbursement automation.
A new phase for Natural Cycles
Founded in 2013 by Dr Elina Berglund Scherwitzl and Dr.Raoul Scherwitzl, Natural Cycles developed the first direct-to-consumer contraceptive app that has been used by more than three million users worldwide. The NC° app is powered by an algorithm that uses body temperature to determine each user's daily fertility status. Users can manually take their body temperature with a thermometer or sync overnight temperature trend data from an Oura Ring or Apple Watch when they wake up.
Natural Cycles remains the only digital form of birth control on the market cleared by regulators in the United States (FDA), Europe (TÜV SÜD), Canada (Health Canada), Australia (TGA), Singapore (HSA), and South Korea (MFDS).
The company became profitable in 2022 and has seen 70% year on year growth in annual recurring revenue within the first four months of 2024.
“We’ve experienced profitable growth over the last few years as women actively seek more birth control options and we’re excited to welcome the next phase of Natural Cycles journey together with Lauxera Capital Partners and Point72 Private Investments,” said Dr. Raoul Scherwitzl, co-founder and CEO of Natural Cycles.
“We look forward to leveraging their expertise to fulfill Natural Cycles’ mission of making hormone-free birth control more accessible and combining technology and science to fill the gaps in underserved areas of women’s health.”
Increasing support throughout the fertility journey
Earlier in May, Natural Cycles launched NC° Postpartum, new functionality within the Natural Cycles app specifically tailored to help guide new mums recovering physically and mentally from childbirth.
NC° Postpartum builds on the other three modes already available within the Natural Cycles app – NC° Birth Control, NC° Plan Pregnancy, and NC° Follow Pregnancy – providing users with support throughout their fertility journey.
"Our mission at Lauxera is to partner with ambitious entrepreneurs transforming the future of medicine with unique technology. The visionary Natural Cycles team has built an exceptional company delivering profitable growth supported by unique clinical and regulatory business moats,” said Samuel Levy, founding partner of Lauxera Capital Partners.
“We are delighted to partner with Elina, Raoul and their team to offer women an alternative to traditional approaches without the side effects and compromises."
As part of the investment, Levy will join Natural Cycles’ Board of Directors.
Lauxera Capital Partners and Point72 Private Investments join Natural Cycles’ current distinguished investors, which include EQT Ventures, Samsung Ventures, Heartcore Capital, Headline, and Bonnier Ventures.